|
1
|
Senni M, Paulus WJ, Gavazzi A, Fraser AG,
Díez J, Solomon SD, Smiseth OA, Guazzi M, Lam CS, Maggioni AP, et
al: New strategies for heart failure with preserved ejection
fraction: The importance of targeted therapies for heart failure
phenotypes. Eur Heart J. 35:2797–2815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Majmudar MD, Keliher EJ, Heidt T,
Leuschner F, Truelove J, Sena BF, Gorbatov R, Iwamoto Y, Dutta P,
Wojtkiewicz G, et al: Monocyte-directed RNAi targeting CCR2
improves infarct healing in atherosclerosis-prone mice.
Circulation. 127:2038–2046. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Varela A, Mavroidis M, Katsimpoulas M,
Sfiroera I, Kappa N, Mesa A, Kostomitsopoulos NG and Cokkinos DV:
The neuropro-tective agent rasagiline mesylate attenuates cardiac
remodeling after experimental myocardial infarction. ESC Heart
Fail. 4:331–340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharp TE III, Schena GJ, Hobby AR,
Starosta T, Berretta RM, Wallner M, Borghetti G, Gross P, Yu D,
Johnson J, et al: Cortical bone stem cell therapy preserves cardiac
structure and function after myocardial infarction. Circ Res.
121:1263–1278. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagpal V, Rai R, Place AT, Murphy SB,
Verma SK, Ghosh AK and Vaughan DE: MiR-125b is critical for
fibroblast-to-myofibroblast transition and cardiac fibrosis.
Circulation. 133:291–301. 2016. View Article : Google Scholar
|
|
6
|
Hodgkinson CP, Kang MH, Dal-Pra S,
Mirotsou M and Dzau VJ: MicroRNAs and cardiac regeneration. Circ
Res. 116:1700–1711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Lang Y, Guo L, Pei Y, Hao S,
Liang Z, Su G, Shu L, Liu H, Huang C and Xu J: MicroRNA-323a-3p
promotes pressure overload-induced cardiac fibrosis by targeting
TIMP3. Cell Physiol Biochem. 50:2176–2187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee YE, Hong CY, Lin YL and Chen RM:
MicroRNA-1 participates in nitric oxide-induced apoptotic insults
to MC3T3-E1 cells by targeting heat-shock protein-70. Int J Biol
Sci. 11:246–255. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martinez EC, Lilyanna S, Wang P, Vardy LA,
Jiang X, Armugam A, Jeyaseelan K and Richards AM: MicroRNA-31
promotes adverse cardiac remodeling and dysfunction in ischemic
heart disease. J Mol Cell Cardiol. 112:27–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McIlwain DR, Berger T and Mak TW: Caspase
functions in cell death and disease. Cold Spring Harb Perspect
Biol. 5:pp. a0086562013, View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Communal C, Sumandea M, de Tombe P, Narula
J, Solaro RJ and Hajjar RJ: Functional consequences of caspase
activation in cardiac myocytes. Proc Natl Acad Sci USA.
99:6252–6256. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park JK, Doseff AI and Schmittgen TD:
MicroRNAs targeting caspase-3 and-7 in PANC-1 cells. Int J Mol Sci.
19:E12062018. View Article : Google Scholar
|
|
13
|
Bozi LHM and Campos JC: Targeting the
ubiquitin proteasome system in diabetic cardiomyopathy. J Mol Cell
Cardiol. 109:61–63. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Powell SR, Herrmann J, Lerman A, Patterson
C and Wang X: The ubiquitin-proteasome system and cardiovascular
disease. Prog Mol Biol Transl Sci. 109:295–346. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schmidt M and Finley D: Regulation of
proteasome activity in health and disease. Biochim Biophys Acta.
1843.13–25. 2014.
|
|
16
|
Gilda JE and Gomes AV: Proteasome
dysfunction in cardiomy-opathies. J Physiol. 595:4051–4071. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han QY, Wang HX, Liu XH, Guo CX, Hua Q, Yu
XH, Li N, Yang YZ, Du J, Xia YL and Li HH: Circulating E3 ligases
are novel and sensitive biomarkers for diagnosis of acute
myocardial infarction. Clin Sci (Lond). 128:751–760. 2015.
View Article : Google Scholar
|
|
18
|
Zhang M, Sun D, Li S, Pan X, Zhang X, Zhu
D, Li C, Zhang R, Gao E and Wang H: Lin28a protects against cardiac
ischaemia/reperfu-sion injury in diabetic mice through the
insulin-PI3K-m TOR pathway. J Cell Mol Med. 19:1174–1182. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei L, Sun D, Yin Z, Yuan Y, Hwang A,
Zhang Y, Si R, Zhang R, Guo W, Cao F and Wang H: A PKC-beta
inhibitor protects against cardiac microvascular ischemia
reperfusion injury in diabetic rats. Apoptosis. 15:488–498. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Romaine SP, Tomaszewski M, Condorelli G
and Samani NJ: MicroRNAs in cardiovascular disease: An introduction
for clinicians. Heart. 101:921–928. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wong LL, Wang J, Liew OW, Richards AM and
Chen YT: MicroRNA and heart failure. Int J Mol Sci. 17:5022016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bronze-da-Rocha E: MicroRNAs expression
profiles in cardiovascular diseases. Biomed Res Int.
2014.985408:2014.
|
|
23
|
Li J, Dong X, Wang Z and Wu J: MicroRNA-1
in cardiac diseases and cancers. Korean J Physiol Pharmacol.
18:359–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hao YL, Fang HC, Zhao HL, Li XL, Luo Y, Wu
BQ, Fu MJ, Liu W, Liang JJ and Chen XH: The role of microrna-1
targeting of mapk3 in myocardial ischemia-reperfusion injury in
rats undergoing sevoflurane preconditioning via the PI3k/Akt
pathway. . Am J Physiol Cell Physiol. 315:C380–C388. 2018.
View Article : Google Scholar
|
|
25
|
Glass C and Singla DK: MicroRNA-1
transfected embryonic stem cells enhance cardiac myocyte
differentiation and inhibit apoptosis by modulating the PTEN/Akt
pathway in the infarcted heart. . Am J Physiol Heart Circ Physiol.
301:H2038–H2049. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng Y, Tan N, Yang J, Liu X, Cao X, He
P, Dong X, Qin S and Zhang C: A translational study of circulating
cell-free microRNA-1 in acute myocardial infarction. . Clin Sci
(Lond). 119:87–95. 2010. View Article : Google Scholar
|
|
27
|
Besser J, Malan D, Wystub K, Bachmann A,
Wietelmann A, Sasse P, Fleischmann BK, Braun T and Boettger T:
MiRNA-1/133a clusters regulate adrenergic control of cardiac
repolarization. PLoS One. 9:pp. e1134492014, View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Portbury AL, Ronnebaum SM, Zungu M,
Patterson C and Willis MS: Back to your heart: Ubiquitin proteasome
system-regulated signal transduction. . J Mol Cell Cardiol.
52:526–537. 2012. View Article : Google Scholar
|
|
29
|
Pagan J, Seto T, Pagano M and Cittadini A:
Role of the ubiquitin proteasome system in the heart. . Circ Res.
112:1046–1058. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barac YD, Emrich F, Krutzwakd-Josefson E,
Schrepfer S, Sampaio LC, Willerson JT, Robbins RC, Ciechanover A,
Mohr FW, Aravot D and Taylor DA: The ubiquitin-proteasome system: A
potential therapeutic target for heart failure. . J Heart Lung
Transplant. 36:708–714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Divald A, Kivity S, Wang P, Hochhauser E,
Roberts B, Teichberg S, Gomes AV and Powell SR: Myocardial ischemic
preconditioning preserves postischemic function of the 26S
proteasome through diminished oxidative damage to 19S regulatory
particle subunits. . Circ Res. 106:1829–1838. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu N, Liu C, Li X, Liao S, Song W, Yang
C, Zhao C, Huang H, Guan L, Zhang P, et al: A novel proteasome
inhibitor suppresses tumor growth via targeting both 19S proteasome
deubiquitinases and 20S proteolytic peptidases. Sci Rep.
4:52402014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hussain AS, Hari P, Brazauskas R,
Arce-Lara C, Pasquini M, Hamadani M and D'Souza A: Changes in
cardiac biomarkers with bortezomib treatment in patients with
advanced cardiac amyloidosis. . Am J Hematol. 90:E2122015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Calise J and Powell SR: The ubiquitin
proteasome system and myocardial ischemia. . Am J Physiol Heart
Circ Physiol. 304:H337–H349. 2013. View Article : Google Scholar
|
|
35
|
Day SM: The ubiquitin proteasome system in
human cardiomy-opathies and heart failure. . Am J Physiol Heart
Circ Physiol. 304:H1283–H1293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Haghikia A, Missol-Kolka E, Tsikas D,
Venturini L, Brundiers S, Castoldi M, Muckenthaler MU, Eder M,
Stapel B, Thum T, et al: Signal transducer and activator of
transcription 3-mediated regulation of miR-199a-5p links
cardiomyocyte and endothelial cell function in the heart: A key
role for ubiquitin-conjugating enzymes. Eur Heart J. 32:1287–1297.
2011. View Article : Google Scholar
|
|
37
|
Wang H, Lai Y, Mathis BJ, Wang W, Li S, Qu
C, Li B, Shao L, Song H, Janicki JS, et al: Deubiquitinating enzyme
CYLD mediates pressure overload-induced cardiac maladaptive
remodeling and dysfunction via downregulating Nrf2. J Mol Cell
Cardiol. 84:143–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang F, Lerman A and Herrmann J:
Dysfunction of the ubiquitin-proteasome system in atherosclerotic
cardiovascular disease. . Am J Cardiovasc Dis. 5:83–100. 2015.
|
|
39
|
Yeh YH, Hsu LA, Chen YH, Kuo CT, Chang GJ
and Chen WJ: Protective role of heme oxygenase-1 in atrial
remodeling. . Basic Res Cardiol. 111:582016. View Article : Google Scholar
|
|
40
|
Tang Y, Zheng J, Sun Y, Wu Z, Liu Z and
Huang G: MicroRNA-1 regulates cardiomyocyte apoptosis by targeting
Bcl-2. . Int Heart J. 50:377–387. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang
X, Wang D, Krall TJ, Delphin ES and Zhang C: MicroRNA expression
signature and the role of microRNA-21 in the early phase of acute
myocardial infarction. . J Biol Chem. 284:29514–29525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yin C, Salloum FN and Kukreja RC: A novel
role of microRNA in late preconditioning: Upregulation of
endothelial nitric oxide synthase and heat shock protein 70. . Circ
Res. 104:572–575. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Naga Prasad SV, Duan ZH, Gupta MK,
Surampudi VS, Volinia S, Calin GA, Liu CG, Kotwal A, Moravec CS,
Starling RC, et al: Unique microRNA profile in end-stage heart
failure indicates alterations in specific cardiovascular signaling
networks. J Biol Chem. 284:27487–27499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. . Curr Biol. 12:735–739.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu C, Tian Y, Xu H, Pan B, Terpstra EM, Wu
P, Wang H, Li F, Liu J and Wang X: Inadequate
ubiquitination-proteasome coupling contributes to myocardial
ischemia-reperfusion injury. . J Clin Invest. 128:5294–5306. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Adams B, Mapanga RF and Essop MF: Partial
inhibition of the ubiquitin-proteasome system ameliorates cardiac
dysfunction following ischemia-reperfusion in the presence of high
glucose. . Cardiovasc Diabetol. 14:942015. View Article : Google Scholar
|
|
47
|
Manne RK, Agrawal Y, Bargale A, Patel A,
Paul D, Gupta NA, Rapole S, Seshadri V, Subramanyam D, Shetty P and
Santra MK: A microRNA/Ubiquitin ligase feedback loop regulates
slug-mediated invasion in breast cancer. . Neoplasia. 19:483–495.
2017. View Article : Google Scholar : PubMed/NCBI
|
